The gut microbiome plays a crucial role in cancer treatment outcomes by influencing responses to therapies like immunotherapy and chemotherapy. Research indicates that a diverse microbiome enhances immune modulation, improves treatment efficacy, and can even convert non-responders to responders through fecal microbiota transplantation. Patients should focus on maintaining gut health through a fiber-rich diet, discussing probiotic use with oncologists, and considering clinical trials exploring microbiome-related treatments. Understanding this connection can empower patients during their cancer journey.
